i
Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020
-
February 2021
Source: Emerg Infect Dis. 27(2):628-631
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating seroprevalence in low prevalence settings.
-
Subjects:
-
Source:
-
Pubmed ID:33496235
-
Pubmed Central ID:PMC7853542
-
Document Type:
-
Place as Subject:
-
Location:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
-
gif jpeg pdf xml
More +